Vnitr Lek 2009, 55(3):173-178
Autologous Bone Marrow Stem Cell Transplantation in Patients with End-Stage Chronical Critical Limb Ischemia and Diabetic Foot
- 1 Radiodiagnostic Institute University Hospital Ostrava-Poruba, head of the department Jana Chmelová, MD, PhD.
- 2 Hemato-Oncological Center University Hospital Ostrava-Poruba, head Jaromír Gumulec, MD
- 3 Henderson Research Center - McMaster University Hamilton, Ontario, Canada, director Dr. Jeffrey Weitz, MD, FRCP(C), FACP
- 4 Children's Hospital, Dana-Farber Cancer Institute, Harvard MU, Boston, USA, president and Chief Executive Officer Edward J. Benz, Jr., MD
A total 37 patients suffering from end stage-IV Fontaine (CLI and diabetic foot) with an ulcerated limb in whom all previous therapeutic strategies failed (e. g. surgical revascularization and endovascular repair) were selected and underwent local transplantation of Autologous Bone Marrow Stem Cells (ABMSCs). The efficacy/safety of this therapy was assessed by using several endpoints such as (a) prevention of amputation, (b) wound healing and (c) degree of angiogenesis. In order to assess the limb ischemia and hypoxia the several tests and measurements were performed pre- and post transplantation at a variety of time intervals. The measurements include: TP-toe pressure measurements (by Periflux 5000 Laser Doppler and Oxymetry system), SPP-skin perfusion pressure, ABI-ankle brachial index, LDP-Laser Doppler baseline and heat perfusion assessment, TcpO2 without and with O2 provocation inhalation test. In addition, a battery of biochemical and hematological tests of peripheral venous blood samples and bone marrow analysis were performed. Limb salvage was 81% in 30 patients, 7 patients (19%) were amputated for terminal severe ischemia and gangrene progression. In the group of limb salvage patients initial Toe pressure 23.119 (std. error 5.358) increased in 90 days follow-up into 29.888 (std. error 5.99), Toe brachial index increased from 0.1469 (std. 0.0326) to 0.1991(std. 0.401). In LASER doppler and TcpO2, TcpCO2 tissue perfusion examination TcpO2% Increase after O2 provocation inhalation test was elevated from 162.95 ( %) to 229.86% which confirmed a very good tissue vasoreactivity after BMSC transplantation.
Keywords: critical limb ischemia; diabetic foot; bon marrow stem cells; transplantation
Received: February 3, 2009; Published: March 1, 2009 Show citation
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- Cipolleschi MG, Dello Sbarba P, Olivotto M. The Role of Hypoxia in the Maintenance of Hematopoietic Stem Cells. Blood 1993; 82: 2031-2037.
Go to original source...
- Asahara T, Masuda H, Takahaski T et al. Bone Marrow Origin of Endothelial Progenitor Cells Responsible for Postnatal Vasculogenesis in Physiological and Pathological Neovascularization. Circ Res 1999; 85: 221-228.
Go to original source...
Go to PubMed...
- Shintani S, Murohara T, Ikeda H et al. Augmentation of Postnatal Neovascularization with Autologous Bone Marrow Transplantation. Circulation 2001; 103: 897-903.
Go to original source...
Go to PubMed...
- Murayama T, Tepper OM, Silver M et al. Determination of Bone Marrow-Derived Progenitor Cell Significance in Angiogenic Growth Factor-Induced Neovascularization in Vivo. Exp Hematol 2002; 30: 967-972.
Go to original source...
Go to PubMed...
- Rafii S, Lyden D. Therapeutic Stem Progenitor Cell Transplantation for Organ Vascularization and Regeneration. Nat Med 2003; 9: 702-712.
Go to original source...
Go to PubMed...
- Tepper O, Capla JM, Galiano RD et al. Adult Vasculogenesis Occurs Through in Situ Recruitment, Proliferation, and Tubulization of Circulating Bone Marrow-Derived Cells. Blood 2005; 95: 1068-1077.
Go to original source...
Go to PubMed...
- Urbich C, Dimmeler S. Current Progenitor Cells: Characterization and Role in Vascular Biology. Circ Res 2004; 95: 343-353.
Go to original source...
Go to PubMed...
- Hamano K, Li TS, Kobayashi T, Tanaka N et al. The Induction of Angiogenesis by the Implantation of Autologous Bone Marrow Cells: A Novel and Simple Therapeutic Method. Surgery 2001; 130: 44-54.
Go to original source...
Go to PubMed...
- Yuyama E, Matsubara H, Murohara T et al. Therapeutic Angiogenesis for Patients with Limb Ischemia by Autologous Transplantation of Bone-Marrow Cells: A Pilot Study and a Randomised Controlled Trial. Lancet 2002; 360: 427-435.
Go to original source...
Go to PubMed...
- Esato K, Hamano K, Li TS et al. Neovascularization Induced by Autlogous Bone Marrow Cell Implantation in Peripheral Arterial Disease. Cell Transplant 2002; 11: 747-752.
Go to original source...
Go to PubMed...
- Al-Khaldi A, Al-Sabti H, Galipeau J et al. Therapeutic Angiogenesis Using Autlogous Bone Marrow Stromal Cells: Improved Blood Flow in a Chronic Limb Ischemia Model. Ann Thorac Surg 2003; 75: 204-209.
Go to original source...
Go to PubMed...
- Saigawa T, Kato K, Ozawa et al. Clinical Application of Bone Marrow Implantation in Patients with Arteriosclerosis Obliterans, and the Association between Efficacy and the Number of Implanted Bone Marrow Cells. Circ J 2004; 68: 1189-1193.
Go to original source...
Go to PubMed...
- Amann B, Lüdemann C, Rückert R et al. Design and rationale of a randomized, double-blind, placebo-controlled phase III study for autologous bone marrow cell transplantation in critical limb ischemia. The Bone Marrow Stem Outcomes trial in Critical limb Ischemia (BONMOT-CLI). Vasa 2008; 37: 319-325.
Go to original source...
Go to PubMed...